External radiotherapy versus expectancy in localized prostate cancer

External radiotherapy versus expectancy in low-intermediate risk localized prostate cancer: a randomized trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN36505257

Enrollment

320

Registered

2011-09-26

Start date

1986-04-23

Completion date

Unknown

Last updated

2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer Cancer Malignant neoplasm of prostate

Interventions

Expectancy: Patients included: 107 out of (130) 160, Patients followed until symptomatic clinical progression, and then offered radiotherapy Radiotherapy: Patients included: 107 out of (130) 160, Tre

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Patients with verified localized prostate cancer, T1-T2b, pN0, Grade 1 and 2, M0 2. Age less than or equal to 75 years 3. Surgical obturatorious lymph node staging, with no signs of positive lymph nodes 4. No signs on metastasis after clinical investigation, bone scan and pulmonary X-ray 5. No previous treatment against their prostate cancer 6. No other known malign or benign disease that would shorten their life?s in relation to a healthy population 7. Patients approval of participation

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the long follow up program

Design outcomes

Primary

Measure	Time frame
1. Progression Free survival 2. Overall survival	—

Secondary

Measure	Time frame
Morbidity	—

Countries

Denmark, Norway, Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026